Friday, July 10, 2026

pharma · Hepatitis C Virus Infection · Chronic Hepatitis B

Gilead Sciences Ireland

Gilead Sciences Ireland trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.

333 Lakeside Drive, Foster City, CA 94404, US HQ
1987 Founded
14,602 Employees
EMA registrant Type
Company details
Status
Public
HQ
333 Lakeside Drive, Foster City, CA 94404, US
Founded
1987
Employees
14,602
Programs
26
Drugs
17
Patents
0
Intelligence · Clinical Trials

Gilead Sciences Ireland clinical trials

Registry index of 30 ClinicalTrials.gov studies linked to Gilead Sciences Ireland programs — each row shows trial ID, program name, phase, status, and indication.

Gilead Sciences Ireland trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Gilead Sciences Ireland.

  1. VOX — Phase 2

    Clinical update
  2. SOF — Phase 2

    Clinical update
  3. SOF — Phase 2

    Clinical update
  4. Sacituzumab Govitecan-hziy — Phase 3

    Clinical update
  5. COBI — Phase 3

    Clinical update
  6. Tenofovir DF — Phase 3

    Clinical update
  7. Presatovir — Phase 2

    Clinical update
  8. AZLI 75 mg two times a day (BID)/ three times a day (TID) — Phase 3

    Clinical update

Trial registry

30 studies